Olivier Danos
Direttore Tecnico/Scientifico/R&S presso REGENXBIO INC.
Patrimonio netto: 460 826 $ in data 30/04/2024
Posizioni attive di Olivier Danos
Società | Posizione | Inizio | Fine |
---|---|---|---|
REGENXBIO INC. | Direttore Tecnico/Scientifico/R&S | 28/03/2017 | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Corporate Officer/Principal | - | - |
Direttore/Membro del Consiglio | - | - | |
Profilomic SA
Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | Direttore/Membro del Consiglio | 27/10/2016 | - |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | - | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 12/10/2021 | - |
Independent Dir/Board Member | 12/10/2021 | - |
Storia della carriera di Olivier Danos
Precedenti posizioni note di Olivier Danos
Società | Posizione | Inizio | Fine |
---|---|---|---|
LYSOGENE | Direttore/Membro del Consiglio | 01/01/2009 | 01/04/2018 |
Fondatore | 01/01/2009 | 01/04/2018 | |
BIOGEN INC. | Corporate Officer/Principal | 23/09/2014 | 01/03/2017 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Direttore Tecnico/Scientifico/R&S | 01/01/1998 | 01/12/2005 |
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | 01/06/1994 | 01/11/1996 |
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░ ░░░░ ░░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░ ░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Olivier Danos
University of Orsay | Graduate Degree |
Statistiche
Distribuzione geografica
Francia | 10 |
Stati Uniti | 5 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Settori
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOGEN INC. | Health Technology |
LYSOGENE | Commercial Services |
REGENXBIO INC. | Health Technology |
Aziende private | 10 |
---|---|
Université Paris Diderot-Paris 7 | Consumer Services |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Health Technology |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Health Technology |
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
European Society of Gene & Cell Therapy | |
Profilomic SA
Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | Health Services |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Olivier Danos
- Esperienza